Price T Rowe Associates Inc Bio Xcel Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$10.25 - $22.43 $1,834 - $4,014	179 Added 1.09%	16,576 $356,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $18,463 - $29,518	1,650 Added 11.19%	16,397 $194,000
Q2 2022 Aug 15, 2022	BUY	$9.03 - $21.55 $7,169 - $17,110	794 Added 5.69%	14,747 $195,000
Q1 2022 May 16, 2022	BUY	$15.0 - $22.83 $13,350 - $20,318	890 Added 6.81%	13,953 $292,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $47,744 - $83,268	2,373 Added 22.2%	13,063 $266,000
Q3 2021 Nov 15, 2021	BUY	$23.84 - $32.03 $1,454 - $1,953	61 Added 0.57%	10,690 $324,000
Q2 2021 Aug 16, 2021	SELL	$29.06 - $38.83 $24,119 - $32,228	-830 Reduced 7.24%	10,629 $309,000
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $3,435 - $5,684	88 Added 0.77%	11,459 $495,000
Q4 2020 Feb 16, 2021	BUY	$42.46 - $56.58 $482,812 - $643,371	11,371 New	11,371 $525,000

8.63M

34.5K

59.4K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $66.7M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

Stay updated on Price T Rowe Associates Inc with notifications on news.